Bayer is finally launching Precose (acarbose)

Bayer is finally launching Precose (acarbose)...a novel drug for type II, or non-insulin-dependent, diabetes.

Precose is an alpha-glucosidase inhibitor. Blocking this enzyme in the intestine slows the breakdown of carbohydrates to glucose. This reduces hyperglycemia...especially after meals.

You can use Precose alone...or with other antidiabetic meds.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote